Last Updated: May 15, 2024
blincyto.com has 4 NS records, 3 A records, 0 AAAA records, 1 MX records, and 0 TXT records. Name servers for blincyto.com are ns-1248.awsdns-28.org, ns-111.awsdns-13.com, ns-587.awsdns-09.net, ns-1901.awsdns-45.co.uk. A records for blincyto.com are 54.68.164.41, 52.89.124.169, 52.13.84.47. MX records that process @blincyto.com email are amgen-com.mail.protection.outlook.com. We have observed blincyto.com to have 7 subdomains. A subdomain count of 7 is considered a small digital footprint. The domain's primary website is hosted on a awselb/2.0 web server at 52.89.124.169 in United States. The website's description is: "learn about blincyto® (blinatumomab), a treatment for b-cell precursor acute lymphoblastic leukemia (all). see safety info, including boxed warnings." As of May 15, 2024, blincyto.com does not have any threat intelligence reports of concern.
Search DigitalStakeout Footprint to find another asset.
54.68.164.41
52.89.124.169
52.13.84.47
No DNS AAAA records
amgen-com.mail.protection.outlook.com
ns-1248.awsdns-28.org
ns-111.awsdns-13.com
ns-587.awsdns-09.net
ns-1901.awsdns-45.co.uk
No DNS TXT records
blincyto.com has 7 subdomains in our inventory.
awselb/2.0
United States
og:description: learn about blincyto® (blinatumomab), a treatment for b-cell precursor acute lymphoblastic leukemia (all). see safety info, including boxed warnings.
og:type: website
og:image: https://www.blincyto.com/-/media/themes/amgen/blincyto/blincyto/images/blincyto-blinatumomab-for-injection.png
og:title: b-cell precursor all treatment | blincyto® (blinatumomab)
og:url: https://www.blincyto.com
No certificate log entry found for blincyto.com. Please check back at a later time.